{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:45:20Z","timestamp":1782942320600,"version":"3.54.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    Anticoagulation after left-sided bioprosthetic valve replacement or mitral valve repair in patients with atrial fibrillation (AF) remains uncertain, as decisions must balance prevention of thromboembolism against bleeding risk in a heterogeneous postoperative population. Although vitamin K antagonists (VKAs) have long been the standard of care, expanding real-world use of direct oral anticoagulants (DOACs) has created an urgent need to define their comparative effectiveness and safety in this setting. We performed a systematic review and meta-analysis of randomized and observational studies comparing DOACs with VKAs in patients with AF after surgical left-sided bioprosthetic valve replacement or mitral valve repair. The primary outcome was ischemic stroke; secondary outcomes included composite thromboembolic events, major bleeding, and all-cause mortality. Pooled risk ratios were estimated using random-effects models, with prespecified subgroup and sensitivity analyses to explore clinical heterogeneity. Fourteen studies including 15,877 patients met inclusion criteria. Compared with VKAs, DOACs were associated with a lower observed risk of ischemic stroke, although this finding was largely driven by patients with aortic bioprosthetic valves. Across analyses, heterogeneity was moderate, and no significant differences were observed for composite thromboembolic events, major bleeding, or all-cause mortality. These findings suggest that DOACs may be a reasonable alternative to VKAs in selected patients with AF after surgical valve intervention. However, the dependence of treatment effect on valve type underscores that left-sided valve populations should not be treated as clinically interchangeable. Anticoagulation decisions should be individualized, integrating valve position, surgical substrate, thromboembolic risk, bleeding risk, and the strength of available evidence.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000001386","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:00:27Z","timestamp":1782939627000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","author":[{"given":"Norma N.","family":"Gamarra-Valverde","sequence":"first","affiliation":[{"name":"Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado, Lima, Peru; \u2020Division of Internal Medicine, Universidad de Costa Rica, San Jose, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susimar Picado","family":"Loaiza","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Federal University of Para\u00edba, Jo\u00e3o Pessoa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Asif","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Railla","family":"Silva","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Universidade Federal do Cear\u00e1, Cear\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Melo","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrunalini","family":"Dandamudi","sequence":"additional","affiliation":[{"name":"Department of Heart Failure, Division of Cardiology, Montefiore Einstein Hospital, New Rochelle, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Delgado","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G.","family":"Batista","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Federal University of Para\u00edba, Jo\u00e3o Pessoa, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhordan","family":"Chilon","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Universidad Peruana de Ciencias Aplicadas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"Giorgi","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Hospital S\u00edrio-Libanes, S\u00e3o Paulo, Brazil"},{"name":"Division of Internal Medicine, Hospital Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Barbagelata","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina"},{"name":"Division of Cardiology, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"R1-20260701","first-page":"e93","article-title":"Heart disease and stroke statistics\u20142023 update: a report from the American Heart Association.","volume":"147","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"R2-20260701","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge.","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"R3-20260701","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery.","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"R4-20260701","first-page":"e340","article-title":"ACC\/AHA 2004 guideline update for coronary artery bypass graft surgery.","volume":"110","author":"Eagle","year":"2004","journal-title":"Circulation"},{"key":"R5-20260701","first-page":"515","article-title":"Predictors and outcome of atrial fibrillation after isolated aortic valve surgery: a multicenter study.","volume":"148","author":"Paparella","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-20260701","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.athoracsur.2009.01.064","article-title":"Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.","volume":"87","author":"Gammie","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R7-20260701","first-page":"1272","article-title":"Late incidence and determinants of persistent or recurrent atrial fibrillation after mitral valve surgery.","volume":"129","author":"Ruel","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R8-20260701","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve.","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N Engl J Med"},{"key":"R9-20260701","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"Edoxaban for the Prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves.","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation"},{"key":"R10-20260701","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jacc.2016.12.031","article-title":"Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.","volume":"69","author":"De Caterina","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260701","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1253\/circj.CJ-22-0226","article-title":"Comparison of direct oral anticoagulants and warfarin in patients with atrial fibrillation and an aortic bioprosthetic valve.","volume":"86","author":"Miyake","year":"2022","journal-title":"Circ J"},{"key":"R12-20260701","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40261-020-00939-x","article-title":"Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements.","volume":"40","author":"Pasciolla","year":"2020","journal-title":"Clin Drug Investig"},{"key":"R13-20260701","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5603\/CJ.a2021.0158","article-title":"NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement.","volume":"29","author":"Piepiorka-Broniecka","year":"2022","journal-title":"Cardiol J"},{"key":"R14-20260701","doi-asserted-by":"crossref","first-page":"e026666","DOI":"10.1161\/JAHA.122.026666","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair.","volume":"11","author":"Mentias","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R15-20260701","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2021.01.127","article-title":"Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial.","volume":"165","author":"Shim","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R16-20260701","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.repc.2024.02.013","article-title":"Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery.","volume":"43","author":"Costa","year":"2024","journal-title":"Rev Port Cardiol"},{"key":"R17-20260701","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.clinthera.2019.10.008","article-title":"Clinical benefit of direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic heart valves.","volume":"41","author":"Russo","year":"2019","journal-title":"Clin Ther"},{"key":"R18-20260701","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.","volume":"42","author":"Guimar\u00e3es","year":"2019","journal-title":"Clin Cardiol"},{"key":"R19-20260701","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease.","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"R20-20260701","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:00:29Z","timestamp":1782939629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001386","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]}}}